Form 4 for GNPX Genprex, Inc.
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-27 · accession 0001437749-26-006154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-27 | GNPX | Berger Mark Stanley | Chief Medical Off | F - Tax | $2.00 | -7,168 | 21.7K | -25% | -$14.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-27 | F | D | 7,168 | $2.00 | 21,692 | D | — | — | (F1) Represents shares withheld on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. 2018 Equity Incentive Plan (as amended and restated effective June 30, 2025). |